Why Your Tablet Line May be at Risk

When people think of cleanrooms, they often picture sterile injectable medicines, with operators in full gowning working in Grade A or B environments. It is easy to assume that oral solid dose (OSD) manufacturing, with its tablets, capsules and powders, does not need the same level of rigour.

After all, OSD products are not sterile. But the reality is that cleanroom controls in OSD facilities are just as critical, though the risks and priorities look different.

Tablet Filling Line in OSD Operations.

The Risks Unique to OSD

OSD manufacturing is dominated by powders, and powders generate dust. That dust presents two risks that have nothing to do with sterility but everything to do with patient and worker safety. The first is cross-contamination between products. If traces of one active ingredient migrate into another product line, patients could end up exposed to the wrong drug or an incorrect dose, and in multi-product facilities, this is one of the biggest risks regulators look for.

The second risk is closer to home for the people on the production floor. Highly potent actives, such as certain oncology drugs or hormones, can be hazardous even at very low exposure levels. Without proper containment and cleaning, operators are at risk of inhalation or dermal exposure simply by doing their jobs. Cleanroom controls, in this sense, are not only about protecting patients; they are about protecting the workforce standing right next to the equipment.

What Regulators Expect

Regulators have made their expectations clear, and OSD facilities are not exempt from scrutiny. The FDA frequently cites firms for inadequate segregation of potent compounds, insufficient HVAC zoning, or poor cleaning validation, and the European Medicines Agency and PIC/S emphasise the same themes, with a consistent focus on designing facilities that minimise the risk of cross-contamination. Facilities that rely on minimal measures, such as a simple clean-down between batches of very different products, are unlikely to satisfy an inspector who has seen what happens when that approach fails elsewhere.

What Cleanroom Controls Actually Look Like in OSD

OSD facilities may not need aseptic filling suites, but they do need carefully designed cleanroom environments built around the specific risks dust creates. Zoning and segregation are central to this: high-potency products often require dedicated rooms or suites with physical barriers separating them from other operations, and even within standard production areas, zoning by pressure differentials and airflow direction helps prevent dust from migrating where it shouldn't.

HVAC design carries much of this weight in practice. Air handling systems must be built to prevent contaminated air recirculating into other areas, which is why negative pressure rooms for potent actives are common, alongside high-efficiency filters capable of capturing fine particles. Cleaning validation matters just as much, since residues from powders can be genuinely difficult to remove, particularly from equipment with complex geometries, and validation is what demonstrates that residues are consistently reduced to safe levels rather than simply assumed to be.

Containment equipment has also become a defining feature of modern OSD facilities, from isolators and split-butterfly valves to contained tablet presses, all designed to minimise both operator exposure and product cross-contamination at the source. None of this works, however, without well-designed material and personnel flows. Airlocks for both materials and operators, paired with clear gowning requirements, reduce the risk of contamination travelling between areas in ways that are easy to overlook until they cause a problem.

The Human Factor

Cleanrooms are not just about technology, and people remain the biggest variable in any controlled environment. In OSD facilities, operator practices can easily make or break contamination control. Poor gowning discipline, shortcuts in cleaning, or careless handling of materials can undo even the best-designed facility.

This is why training has to go beyond procedure. Operators need to understand not just the how but the why behind what they are asked to do. Explaining that a tiny trace of cross-contaminant could trigger a patient reaction does more to reinforce good practice than any procedure document on its own, because it connects a small daily action to a real consequence.

A Cost-Effective Investment, Not a Burden

Some firms still see enhanced cleanroom controls as a cost to be minimised. The reality is closer to the opposite: strong contamination control saves money in the long run. Recalls are expensive, reputations are fragile, and regulatory enforcement can shut a facility down entirely. Investing in cleanroom design, robust cleaning programmes, and staff training is what allows OSD manufacturers to avoid these costly disruptions altogether rather than manage them after the fact.

This becomes even more relevant as many OSD facilities now handle a far wider range of products than they once did, from generic tablets to complex formulations with very low dose actives. The more diverse the portfolio, the more critical cleanroom controls become, and the less room there is for the assumption that "it's not sterile, so it doesn't matter."

Conclusion

Cleanrooms in OSD facilities may not look the same as those in sterile manufacturing, but they are no less important. By controlling dust, preventing cross-contamination, and protecting both patients and operators, they provide the foundation for safe and compliant production. Regulators expect it, consumers rely on it, and brands ultimately benefit from the confidence it creates.

📌 Need help designing or remediating your contamination control program? Pharmalliance Consulting Ltd offers hands-on support, training, and gap assessments to ensure your OSD operations are regulatory-ready and quality-driven. Get in touch with our team of contamination control experts to start your compliance journey today.